These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25409386)

  • 21. Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
    Briasoulis E; Pavlidis N; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii106-7. PubMed ID: 18456742
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fizazi K; Greco FA; Pavlidis N; Pentheroudakis G;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi64-8. PubMed ID: 21908507
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.
    Hainsworth JD; Greco FA
    Am Soc Clin Oncol Educ Book; 2018 May; 38():20-25. PubMed ID: 30231392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cancer of unknown origin].
    Losa F; Camacho L; Valencia JB
    Med Clin (Barc); 2007 Jun; 129(1):23-6. PubMed ID: 17570183
    [No Abstract]   [Full Text] [Related]  

  • 25. New look at the old management of unknown primary.
    Dowden S; Miller W
    J Surg Oncol; 2008 Aug; 98(2):71-2. PubMed ID: 18609550
    [No Abstract]   [Full Text] [Related]  

  • 26. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    ESMO.
    Ann Oncol; 2001 Aug; 12(8):1057-8. PubMed ID: 11583184
    [No Abstract]   [Full Text] [Related]  

  • 27. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    Briasoulis E; Tolis C; Bergh J; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metastatic occult primary cancer].
    Aabo K
    Ugeskr Laeger; 1987 Jan; 149(2):76-9. PubMed ID: 3544422
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic and therapeutic approach in cancer of metastatic presentation and unknown origin].
    Losa Gaspà F; Germà Lluch JR; Camacho Cuartero L; Niubó Daniel R; Albareda Boleda JM; Sanuy Jiménez B; Martos Rodríguez A
    Rev Clin Esp; 2002 Nov; 202(11):604-14. PubMed ID: 12392650
    [No Abstract]   [Full Text] [Related]  

  • 30. Occult primary cancer clinical practice guidelines.
    Ettinger DS; Arnoletti JP; Gockerman JP; Handorf C; Havlin KA; Jacobs CD; Javle M; Kvols L; Lenzi R; Rashid A; Rhoades CA; Ridge JA; Saltz L; Shulman LN; Sondak VK; Thompson JA; Twardowski P; Zhen W;
    J Natl Compr Canc Netw; 2005 Mar; 3(2):214-33. PubMed ID: 19817031
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnosis and treatment of cancer of unknown origin].
    Vázquez Rivera F; Barón Duarte FJ; López López R
    An Med Interna; 2000 Nov; 17(11):603-8. PubMed ID: 11322036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site].
    Bišof V; Juretić A; Trivanović D; Dintinjana RD; Sarçević B; Jakić-Razumović J; Ban M; Bošković L; Mise B-; Bura M; Stančić-Rokotov D
    Lijec Vjesn; 2015; 137(3-4):65-9. PubMed ID: 26065281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unknown primary tumors.
    Raber MN; Abbruzzese JL; Frost P
    Curr Opin Oncol; 1992 Feb; 4(1):3-9. PubMed ID: 1591292
    [No Abstract]   [Full Text] [Related]  

  • 34. [The big mystery].
    Delorme S; Jäger D
    Radiologe; 2014 Feb; 54(2):106. PubMed ID: 24493101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neoplasms of unknown primary site].
    Khosravi Shahi P; Del Castillo Rueda A; de Portugal Alvarez J
    An Med Interna; 2004 Oct; 21(10):501-6. PubMed ID: 15511203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer of the unknown primary site.
    Diggs CH
    Wis Med J; 1988 Oct; 87(10):18-20. PubMed ID: 3232395
    [No Abstract]   [Full Text] [Related]  

  • 38. NICE issues guidance on cancer of unknown primary.
    MacReady N
    Lancet Oncol; 2010 Sep; 11(9):824. PubMed ID: 20842777
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoma of Unknown Primary Site With Papillary Renal Cell Carcinoma Features and Without a Kidney Primary Lesion: A Diagnostic and Therapeutic Challenge.
    Ginori A; Spagnoli L; Pacetti P; Martignoni G; Cavazzana A
    Urology; 2022 Jun; 164():304-305. PubMed ID: 35182587
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic imaging in clinical cancer management. Metastases from unknown primary tumors.
    Kagan AR; Steckel RJ
    Invest Radiol; 1988 Jul; 23(7):545-7. PubMed ID: 3049434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.